p21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression

被引:0
|
作者
Kouvidou, C
Stefanaki, K
Dai, Y
Tzardi, M
Koutsoubi, K
Darivianaki, K
Karidi, E
Rontogianni, D
Zois, E
Kakolyris, S
Georgoulias, V
Delides, G
Kanavaros, P
机构
[1] UNIV HOSP,DEPT PATHOL,IRAKLION,GREECE
[2] METAXAS ANTICANC HOSP,DEPT PATHOL,PIRAEUS,GREECE
[3] EVAGELISMOS HOSP,DEPT PATHOL,ATHENS,GREECE
[4] UNIV HOSP,DEPT MED ONCOL,IRAKLION,CRETE,GREECE
关键词
p21; PCNA; p53; MDM-2 and nasopharyngeal carcinoma (NPC);
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the immunohistochemical expression of p21/waf1 protein in 59 cases of nasopharyngeal carcinomas (NPC) and compared p21 expression with PCNA, p53 and mdm2 protein expression. We found p21, PCNA, p53 and mdm2 in 59/59, 59/59, 18/59 and 12/59 nasopharyngeal carcinomas, respectively. We observed a tendency to a relationship between high expression of PCNA (>%5%positivity in tumour cells) and low expression of p21 protein. Parallel p53/p21 protein expression was found in 18 cases. Twelve were also mdm2 positive. This pattern may represent NPC with wild type (wt) p53 since mdm2 and p21 proteins are inducible by wt p53 gene. In these cases p53 protein expression may be due to stabilisation to mdm2 protein. This could be important in the pathogenesis of these cases since mdm2 may deregulate the p53-dependent growth suppressive pathway. Discordant p53-/p21+ protein expression was found in 41 cases. All were also mdm2 negative. This pattern suggests immunohistochemically undetectable wt p53 gene which is able to induce p21 protein expression.
引用
收藏
页码:2615 / 2619
页数:5
相关论文
共 50 条
  • [1] P21/WAF1, p53 and PCNA expression in hepatocellular carcinoma.
    Ng, IOL
    Qin, LF
    Fan, ST
    Ng, M
    [J]. HEPATOLOGY, 1997, 26 (04) : 1310 - 1310
  • [2] MDM-2 protein expression in nasopharyngeal carcinomas. Comparative study with p53 protein expression
    Kanavaros, P
    Kouvidou, C
    Dai, Y
    Tzardi, M
    Datseris, G
    Darivianaki, K
    Rontogianni, D
    Delides, G
    [J]. JOURNAL OF CLINICAL PATHOLOGY-CLINICAL MOLECULAR PATHOLOGY EDITION, 1995, 48 (06): : M322 - M325
  • [3] p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
    Qin, LF
    Ng, IOL
    Fan, ST
    Ng, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (04) : 424 - 428
  • [4] P21/WAF1 expression and p53 mutation status in hepatocellular carcinoma.
    Ng, IOL
    Qin, LF
    Ng, M
    [J]. HEPATOLOGY, 1997, 26 (04) : 1311 - 1311
  • [5] p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1
    Giannikaki, E
    Kouvidou, C
    Tzardi, M
    Stefanaki, K
    Koutsoubi, K
    Gregoriou, M
    Zois, E
    Kakolyris, S
    Mavroudi, C
    Delides, G
    Gregoriou, M
    Georgoulias, V
    Kanavaros, P
    [J]. ANTICANCER RESEARCH, 1997, 17 (3C) : 2123 - 2127
  • [6] p53, mdm-2, and p21 waf-1 in the porokeratoses
    Nelson, C
    Cowper, S
    Morgan, M
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1999, 21 (05) : 420 - 425
  • [7] p21(Waf1/Cip1) and p53 protein expression in breast cancer
    Wakasugi, E
    Kobayashi, T
    Tamaki, Y
    Ito, Y
    Miyashiro, I
    Komoike, Y
    Takeda, T
    Shin, E
    Takatsuka, Y
    Kikkawa, N
    Monden, T
    Monden, M
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (06) : 684 - 691
  • [8] Expression of p53, mdm2, p21/waf1 and bcl-2 proteins in thymomas
    Stefanaki, K
    Rontogianni, D
    Kouvidou, CH
    Bolioti, S
    Delides, G
    Pantelidaki, A
    Sotsiou, F
    Kanavaros, P
    [J]. HISTOPATHOLOGY, 1997, 30 (06) : 549 - 555
  • [9] p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma
    Schmider, A
    Gee, C
    Friedmann, W
    Lukas, JJ
    Press, MF
    Lichtenegger, W
    Reles, A
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 77 (02) : 237 - 242
  • [10] p53 protein expression in non-Hodgkin's lymphoma. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1
    Tzardi, M
    Kouvidou, C
    Panayiotides, I
    Stefanaki, K
    Rontogianni, D
    Zois, E
    Koutsoubi, K
    Eliopoulos, G
    Delides, G
    Kanavaros, P
    [J]. JOURNAL OF CLINICAL PATHOLOGY-CLINICAL MOLECULAR PATHOLOGY EDITION, 1996, 49 (05): : M278 - M282